Ina Oehme
- Molecular Biology top 2%
- Histone Deacetylase Inhibitors Research 43
- Protein Degradation and Inhibitors 32
- Epigenetics and DNA Methylation 12
- Cancer therapeutics and mechanisms 4
- Oncology top 2%
- Peptidase Inhibition and Analysis 9
- Genetics top 5%
- Glioma Diagnosis and Treatment 10
- Neurology top 5%
- Neuroblastoma Research and Treatments 20
- Physiology top 5%
-
- Autophagy in Disease and Therapy 4
- Co-authors
- Olaf WittHedwig E. DeubzerTill MildeMarco LodriniManfred JungWolfgang SipplAndreas von DeimlingAnnette Kopp‐Schneider
- Cited by
- Molecular BiologyOncologyGenetics
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Ina Oehme
60 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Molecular Biology 3.1k
- Oncology 1.1k
- Genetics 261
- Neurology 312
- Physiology 87
Countries citing papers authored by Ina Oehme
This map shows the geographic impact of Ina Oehme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ina Oehme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ina Oehme more than expected).
Fields of papers citing papers by Ina Oehme
This network shows the impact of papers produced by Ina Oehme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ina Oehme. The network helps show where Ina Oehme may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ina Oehme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 27 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 18 | |
| 11 | 2019 | 66 | |
| 12 | 2018 | 28 | |
| 13 | 2018 | 40 | |
| 14 | 2015 | 39 | |
| 15 | 2013 | 17 | |
| 16 | 2012 | 37 | |
| 17 | 2010 | 158 | |
| 18 | 2009 | 53 | |
| 19 | 2008 | 320 | |
| 20 | HDAC family: What are the cancer relevant targets?breakdown → | 2008 | 871 |
About Ina Oehme
Ina Oehme is a scholar working on Neurology, Genetics and Molecular Biology, having authored 65 papers that have together received 3.6k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (43 papers), Protein Degradation and Inhibitors (32 papers), Neuroblastoma Research and Treatments (20 papers), Epigenetics and DNA Methylation (12 papers), Glioma Diagnosis and Treatment (10 papers), Peptidase Inhibition and Analysis (9 papers), Cancer therapeutics and mechanisms (4 papers) and Autophagy in Disease and Therapy (4 papers). The work is most often cited by research in Molecular Biology (3.1k citations), Oncology (1.1k citations) and Genetics (261 citations). Ina Oehme has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Olaf Witt, Hedwig E. Deubzer, Till Milde, Marco Lodrini, Manfred Jung, Wolfgang Sippl, Andreas von Deimling, Annette Kopp‐Schneider, Christophe Romier and E Koeneke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.